Liupanshui
Liupanshui
Liupanshui, Guizhou, China8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Not yet recruiting | Phase 2 | 2026-08-12 | NCT07760155 | |
| A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 3 | 2026-07-14 | NCT06022146 | |
| Asymptomatic TB With Innovative Modified Short-course Regimens | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 4 | 2026-02-11 | NCT06153069 | |
| Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subarachnoid Hemorrhage, Aneurysmal, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Recruiting | Not applicable | 2025-09-08 | NCT06329635 | |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Active, not recruiting | Phase 3 | 2025-09-02 | NCT06649721 | |
| Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 3 | 2025-04-06 | NCT05081401 | |
| Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, mycobacterial infectious disease, tuberculosis | Recruiting | Not stated | 2025-04-01 | NCT06033807 | |
| Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 2 / Phase 3 | 2023-12-11 | NCT05401071 |